Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protocare was a U.S. healthcare services and drug-development company that operated in clinical research and health-services consulting rather than as a therapeutics developer. The business included Protocare Trials, which conducted clinical trials for pharmaceutical, biotechnology, nutrition, and device sponsors across multiple therapeutic areas, and a consulting/services arm that later became associated with Constella Health Strategies. Historical sources indicate that parts of Protocare were sold in 2002, with the clinical trials and development divisions acquired by Radiant Research and the consulting business rebranded into Constella Health Strategies, which was later integrated into UnitedHealth Group. More recent directory-style sources also reference Protocare Sciences and a Concierge Care offering focused on chronic care and remote patient engagement, but these records are inconsistent and appear to reflect legacy or residual corporate records rather than a standalone active biotech company. Overall, Protocare is best understood as a defunct healthcare-services/CRO organization with historical involvement in outsourced clinical development and care-management solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Protocare.